tranexamic acid has been researched along with gabexate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Pilgram, O; Steinmetzer, T; Wenzel, BM; Wiedemeyer, SJA | 1 |
| Shibata, J | 1 |
| Sakamoto, Y; Yahata, M | 1 |
1 review(s) available for tranexamic acid and gabexate
| Article | Year |
|---|---|
[Anti DIC therapy].
Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzamidines; Disseminated Intravascular Coagulation; Gabexate; Guanidines; Heparin; Humans; Protease Inhibitors; Recombinant Proteins; Sepsis; Systemic Inflammatory Response Syndrome; Thrombomodulin; Tranexamic Acid; Wounds and Injuries | 2016 |
2 other study(ies) available for tranexamic acid and gabexate
| Article | Year |
|---|---|
Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding.
Topics: Animals; Antifibrinolytic Agents; Catalytic Domain; Crystallography, X-Ray; Fibrinolysin; Fibrinolysis; Hemorrhage; Humans; Ligands; Molecular Structure; Plasminogen; Protein Binding; Protein Domains | 2020 |
[Studies on fibrinolysis and ascites accumulation associated with peritonitis carcinomatosa--effects of protease inhibitors (PI) on MM2 ascites tumor growth, ascites accumulation and fibrinolysis].
Topics: Animals; Aprotinin; Ascites; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Fibrinolysis; Gabexate; Guanidines; Heparin; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Peritonitis; Plasminogen Activators; Protease Inhibitors; Tranexamic Acid | 1986 |